EUVIMEDEUVIMED entdecken
Crossref

Nephropathy in Diabetes

Ludwig Merker, Thomas Ebert, Erwin Schleicher, Berend Isermann, Martina Guthoff

Experimental and Clinical Endocrinology & Diabetes · 01.04.2025 · 133 (04) · 191-196

DOI: 10.1055/a-2500-1124 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimental and Clinical Endocrinology & Diabetes, erschienen am 01.04.2025. Verfasst von Ludwig Merker und 4 weiteren Autor:innen. Beteiligte Einrichtung: Diabetology Neanderthal, Erkrath, Germany. Die Arbeit nennt 17 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Notice of update The DDG clinical practice guidelines are updated regularly during the second half of the calendar year. Please ensure that you read and cite the respective current version. UPDATES TO CONTENT AND DIFFERENT RECOMMENDATIONS COMPARED TO THE PREVIOUS YEAR’S VERSION Change 1: Therapy section on targeted drug-based progression inhibition updated Reason: New approvals in Germany as well as more recent data on GLP-1 receptor agonists Supporting reference: [ 1 ] Change 2: Overview of diagnostics and the resulting measures for people with chronic renal insufficiency Reason: New guidelines Supporting reference: [ 2 ] Change 3: Recommendations for the use of finerenone as a nonsteroidal mineralocorticoid receptor antagonist in type 2 diabetes and CRI Reason: New guidelines Supporting reference: [ 2 ] and [ 3 ] Change 4: Updated overview of the approval of antidiabetic drugs for chronic renal insufficiency in Germany Reason: New approvals in Germany, new therapy principles Publication History Article published online: 06 May 2025 © 2025. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

Autor:innen und Institutionen

  • Diabetology Neanderthal, Erkrath, Germany.
  • Department of Internal Medicine III - Endocrinology, Nephrology and Rheumatology, University Hospital Leipzig, Leipzig, Germany.
  • Institute for Clinical Chemistry and Pathobiochemistry - Central Laboratory, University Hospital Tübingen, Tübingen, Germany.
  • Institute of Laboratory Medicine, Clinical Chemistry and Molecular Diagnostics, University Hospital Leipzig, Leipzig, Germany.
  • Department of Internal Medicine IV - Diabetology, Endocrinology, Nephrology, University Hospital Tübingen, Germany.

Zitieren

APA

Merker, L., Ebert, T., Schleicher, E., Isermann, B., & Guthoff, M. (2025). Nephropathy in Diabetes. Experimental and Clinical Endocrinology & Diabetes, 133(04), 191-196. https://doi.org/10.1055/a-2500-1124

Vancouver

Merker L, Ebert T, Schleicher E, Isermann B, Guthoff M. Nephropathy in Diabetes. Experimental and Clinical Endocrinology & Diabetes. 2025;133(04):191-196. doi:10.1055/a-2500-1124

BibTeX
@article{Merker2025,
  author = {Merker, Ludwig and Ebert, Thomas and Schleicher, Erwin and Isermann, Berend and Guthoff, Martina},
  title = {Nephropathy in Diabetes},
  journal = {Experimental and Clinical Endocrinology & Diabetes},
  year = {2025},
  volume = {133},
  number = {04},
  pages = {191--196},
  doi = {10.1055/a-2500-1124}
}
Kostenlos starten →